121 related articles for article (PubMed ID: 38466206)
1. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease.
Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK
Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206
[TBL] [Abstract][Full Text] [Related]
2. Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.
Kahaly GJ; Douglas RS; Holt RJ; Sile S; Smith TJ
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):360-372. PubMed ID: 33865501
[TBL] [Abstract][Full Text] [Related]
3. Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease.
Al-Sharif EM; Zhou J; Shoji MK; Acuff K; Liu CY; Korn BS; Kikkawa DO
Ophthalmic Plast Reconstr Surg; 2024 May; ():. PubMed ID: 38722772
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients.
Young SM; Kim JH; Kim YD; Karnsiritanont V; Lang SS; Woo KI
Orbit; 2023 Aug; 42(4):389-396. PubMed ID: 36082627
[TBL] [Abstract][Full Text] [Related]
5. Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease.
Rosenblatt TR; Chiou CA; Yoon MK; Wolkow N; Lee NG; Freitag SK
Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):187-191. PubMed ID: 37791840
[TBL] [Abstract][Full Text] [Related]
6. Teprotumumab for chronic thyroid eye disease.
Ozzello DJ; Dallalzadeh LO; Liu CY
Orbit; 2022 Oct; 41(5):539-546. PubMed ID: 34060414
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Teprotumumab on Eyelid Position in Patients with Thyroid Eye Disease.
Simmons BA; Tran C; Pham CM; Shriver EM
Plast Reconstr Surg Glob Open; 2022 Apr; 10(4):e4287. PubMed ID: 35475287
[TBL] [Abstract][Full Text] [Related]
8. Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.
Byun JS; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):2001-2008. PubMed ID: 29959506
[TBL] [Abstract][Full Text] [Related]
9. Modified Full Thickness Graded Blepharotomy for Upper Eyelid Retraction Associated With Thyroid Eye Disease in East Asians.
Lee J; Lee H; Park M; Baek S
Ann Plast Surg; 2016 Dec; 77(6):592-596. PubMed ID: 26545229
[TBL] [Abstract][Full Text] [Related]
10. Contralateral Mueller's muscle-conjunctiva resection: a therapeutic option in thyroid eye disease patients with unilateral eyelid retraction.
Saonanon P; Potita P
Orbit; 2020 Apr; 39(2):98-101. PubMed ID: 31162982
[No Abstract] [Full Text] [Related]
11. Early Experience With the Clinical Use of Teprotumumab in a Heterogenous Thyroid Eye Disease Population.
Diniz SB; Cohen LM; Roelofs KA; Rootman DB
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):583-591. PubMed ID: 33710036
[TBL] [Abstract][Full Text] [Related]
12. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
[No Abstract] [Full Text] [Related]
13. Nylon Hang Back Sutures in the Repair of Secondary Ptosis Following Overcorrected Dysthyroid Upper Eyelid Retraction.
Shah-Desai S; Azarbod P; Szamocki S; Rose GE
Ophthalmic Plast Reconstr Surg; 2016; 32(1):61-4. PubMed ID: 26505232
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation.
Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450
[TBL] [Abstract][Full Text] [Related]
15. Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Men CJ; Amarikwa L; Pham B; Sears C; Clauss K; Lee BW; Lee WW; Pasol J; Ugradar S; Shinder R; Cockerham K; Wester S; Douglas R; Kossler AL
Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):276-285. PubMed ID: 37972960
[TBL] [Abstract][Full Text] [Related]
16. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
[TBL] [Abstract][Full Text] [Related]
17. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS; Kahaly GJ; Ugradar S; Elflein H; Ponto KA; Fowler BT; Dailey R; Harris GJ; Schiffman J; Tang R; Wester S; Jain AP; Marcocci C; Marinò M; Antonelli A; Eckstein A; Führer-Sakel D; Salvi M; Sile S; Francis-Sedlak M; Holt RJ; Smith TJ
Ophthalmology; 2022 Apr; 129(4):438-449. PubMed ID: 34688699
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous ipsilateral transconjunctival repair of upper and lower eyelid retraction in thyroid-associated ophthalmopathy.
Lee NG; Habib L; Hall J; Freitag SK
Orbit; 2019 Apr; 38(2):124-129. PubMed ID: 29742012
[TBL] [Abstract][Full Text] [Related]
19. Course of upper eyelid retraction in thyroid eye disease.
Lee DC; Young SM; Kim YD; Woo KI
Br J Ophthalmol; 2020 Feb; 104(2):254-259. PubMed ID: 31079052
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy.
Ben Simon GJ; Mansury AM; Schwarcz RM; Lee S; McCann JD; Goldberg RA
Ophthalmology; 2005 May; 112(5):923-32. PubMed ID: 15878077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
